Ropes & Gray represented AvenCell Therapeutics in the transaction, and Wilson Sonsini Goodrich & Rosati advised Novo Holdings and F-Prime Capital on the transaction. AvenCell Therapeutics...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here